...
机译:供体衍生的Car-T细胞用作寄生术干细胞移植的减少强度调理方案,治疗复发/难治急性淋巴细胞白血病:病例报告和对文献的审查
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
ArmyMed Univ Southwest Hosp Ctr Biol Therapy Chongqing 400038 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
ArmyMed Univ Southwest Hosp Ctr Biol Therapy Chongqing 400038 Peoples R China;
ArmyMed Univ Southwest Hosp Ctr Biol Therapy Chongqing 400038 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
ArmyMed Univ Southwest Hosp Ctr Biol Therapy Chongqing 400038 Peoples R China;
ArmyMed Univ Southwest Hosp Ctr Biol Therapy Chongqing 400038 Peoples R China;
Army Mil Med Univ Dept Hematol Xinqiao Hosp Chongqing 400037 Peoples R China;
allogeneic anti-CD19 chimeric antigen receptor T cells; haploidentical hematopoietic stem cell transplantation; acute lymphoblastic leukemia; relapsed and refractory;
机译:供体衍生的Car-T细胞用作寄生术干细胞移植的减少强度调理方案,治疗复发/难治急性淋巴细胞白血病:病例报告和对文献的审查
机译:二次供体衍生的人源化CD19改良的CAR-T细胞在同种异体造血干细胞移植后诱导重复/难治混合表型急性白血病的缓解:案例报告
机译:使用降低强度的条件,成功地将T细胞充足的外周血干细胞从HLA单倍体嵌合母亲移植到患有难治性急性淋巴细胞白血病的女儿。
机译:血管活性肠道多肽诱导调节性树突细胞泰国预防急性移植物与骨髓移植后宿主病和白血病复发
机译:儿童急性淋巴细胞白血病清髓性造血干细胞移植后生存和治疗相关死亡率的回顾性分析。
机译:成功处理复发/难治性髓外骨髓瘤与抗BCMA Car-T细胞疗法其次是Haploidentical造血干细胞移植:案例报告和对当代文学的审查
机译:用于复发/难治性B细胞急性淋巴细胞白血病的Car-T细胞和同种异体造血干细胞移植